Open AccessThe efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analysis of randomized clinical trials
Author(s) -
BiCheng Wang,
Wenxuan Zhang,
BoHua Kuang,
GuoHe Lin
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0275919
Subject(s) - gefitinib , pemetrexed , medicine , tolerability , oncology , lung cancer , hazard ratio , chemotherapy , epidermal growth factor receptor , randomized controlled trial , performance status , cancer , confidence interval , adverse effect , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom